UAS regulatory sequences drive expression of Hsap\TARDBP with an ALS-linked amino acid substitution (G298S).
The expression of Hsap\TARDBPG298S.Scer\UAS.cIb under the control of Scer\GAL4GMR.PS leads to a mild eye phenotype, including retinal degeneration, loss of pigmentation and ommatidial disruption, as compared to controls.
Hsap\TARDBPG298S.UAS.cIb, Scer\GAL4GMR.PS has visible | adult stage phenotype, suppressible | partially by Zzzz\UGGAA22.UAS, Scer\GAL4GMR.PS
Hsap\TARDBPG298S.UAS.cIb, Scer\GAL4GMR.PS has abnormal eye color phenotype, suppressible | partially by Zzzz\UGGAA22.UAS, Scer\GAL4GMR.PS
Hsap\TARDBPG298S.UAS.cIb, Scer\GAL4GMR.PS has eye phenotype, suppressible | partially by Zzzz\UGGAA22.UAS, Scer\GAL4GMR.PS
Hsap\TARDBPG298S.UAS.cIb, Scer\GAL4GMR.PS has ommatidium | adult stage phenotype, suppressible | partially by Zzzz\UGGAA22.UAS, Scer\GAL4GMR.PS
Hsap\TARDBPG298S.UAS.cIb, Scer\GAL4GMR.PS has retina | adult stage phenotype, suppressible | partially by Zzzz\UGGAA22.UAS, Scer\GAL4GMR.PS
The eye defects observed upon the expression of Hsap\TARDBPG298S.Scer\UAS.cIb under the control of Scer\GAL4GMR.PS are partially suppressed by the co-expression of Zzzz\UGGAA22.Scer\UAS.